채용
岗位职责：
- 协助参与原液的微生物限度、细菌内毒素方法确认及报告工作；
- 协助参与制剂的无菌检测方法确认及报告工作；
- 协助参与进厂原辅料、原液、成品及稳定性样品的放行检测工作；
- 协助参与中间控制样品、调查样品、验证样品等的检测工作；
- 协助参与公用系统（水系统、空调系统、压缩空气等）的日常监控工作；
- 协助参与微生物所用的菌种的复苏、传代、使用、储存、处理等工作；
- 协助参与记录、数据分析、报告和存档工作；
- 协助参与部门相关文件的起草工作、检验数据的定期回顾；
- 协助参与微生物OOS、偏差的调查，分析，并提出解决方案；
- 协助参与微生物所用的菌种的复苏、传代、使用、储存、处理等工作；
- 协助参与微生物仪器设备的验证。
任职要求：
- 本科以上学历，生物学、医药等相关专业；
- 具备良好的职业素养、积极性、执行力；
- 了解质量体系管理，熟练使用Office等办公软件。
총 조회수
0
총 지원 클릭 수
0
모의 지원자 수
0
스크랩
0
비슷한 채용공고
Product Engineer
Ingersoll Rand · Shanghai, SH, CN, 200245
Circuit Calibration Methodology Engineer
NVIDIA · China, Shanghai
Systems Infrastructure Software Engineer
NVIDIA · China, Shanghai
Product Engineer
Ingersoll Rand · Wujiang, JS, CN, 215200
Manufacturing Engineer
Emerson · Shanghai, Shanghai, China, CN
BioNTech 소개
BioNTech
PublicBioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
1,001-5,000
직원 수
Mainz that develops immunotherapies
본사 위치
$21.7B
기업 가치
리뷰
4.0
10개 리뷰
워라밸
2.5
보상
3.8
문화
4.2
커리어
3.5
경영진
3.2
75%
친구에게 추천
장점
Innovative and cutting-edge projects
Great team and collaborative environment
Excellent benefits and flexible schedule
단점
Long working hours and high workload
Fast-paced and high-pressure environment
Management and communication issues
연봉 정보
70개 데이터
L2
L3
L4
L5
L6
Mid/L4
Intern
L2 · Data Scientist L2
0개 리포트
$53,767
총 연봉
기본급
$21,507
주식
$26,884
보너스
$5,377
$37,637
$69,897
면접 경험
1개 면접
난이도
3.0
/ 5
소요 기간
14-28주
면접 과정
1
Application Review
2
HR Screen
3
Hiring Manager Interview
4
Panel Interview
5
Final Interview
6
Offer
자주 나오는 질문
Behavioral/STAR
Technical Knowledge
Past Experience
Culture Fit
Problem Solving
뉴스 & 버즈
BioNTech’s BNT323 Achieves Strong Phase 2 Response Rates in Endometrial Cancer - Oncodaily
Oncodaily
News
·
Today
BioNTech And Boehringer Trial Adds Dimension To Small Cell Lung Cancer Story - simplywall.st
simplywall.st
News
·
3d ago
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
medwatch.com
News
·
6d ago
BioNTech and DualityBio report positive data for trastuzumab pamirtecan - Clinical Trials Arena
Clinical Trials Arena
News
·
6d ago